rhenium-186 HEDP

Known as: (186Re)-hydroxyethylidene diphosphonate, Re 186 Hydroxyethylidene Diphosphonate, rhenium-186 hydroxyethylidene diphosphonate 
An synthetic compound containing the organic phosphonate hydroxyethylidene diphosphonate (HEDP) labeled with the radioisotope rhenium Re 186. Re-186… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Two-thirds of patients with metastatic cancer suffer from pain. Pain originating from skeletal metastases is the most common form… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2001
2001
PURPOSE Rhenium-188 hydroxyethylidine diphosphonate (HEDP) is a new and attractive radiopharmaceutical that localizes in skeletal… (More)
Is this relevant?
2000
2000
AIM Several radiopharmaceuticals were compared previously with regard to the efficiency in pain palliation of bone metastases… (More)
Is this relevant?
1999
1999
PURPOSE For patients with metastatic prostate cancer, first results have shown that rhenium-186 (Re-186) hydroxyethylidene… (More)
Is this relevant?
1998
1998
Therapeutic means for patients with disseminated painful bone metastases in breast cancer are strongly limited. There is a big… (More)
Is this relevant?
1997
1997
The aim of this study was to evaluate the efficacy of rhenium-186 hydroxyethyledine diphosphonate (Re-186 HEDP) for pain relief… (More)
Is this relevant?
1996
1996
UNLABELLED Rhenium-186(Sn)-1,1-hydroxyethylidene diphosphonate (186Re-HEDP) has been used for palliation of metastatic bone pain… (More)
Is this relevant?
1996
1996
UNLABELLED Rhenium-186-etidronate has been developed for pain relief of bone metastases and has previously been studied with… (More)
Is this relevant?
1994
1994
Rhenium-186 hydroxyethylidene diphosphonate (186Re-HEDP) has been used for the palliative treatment of metastatic bone pain. A… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1991
1991
Rhenium-186 (tin) hydroxyethylidene diphosphonate (HEDP) is a new radiopharmaceutical that simultaneously localizes in multiple… (More)
Is this relevant?